Arkolith/Insider Trading/RLMD/Form 4

Shenouda Maged

Chief Financial OfficerRELMADA THERAPEUTICS, INC. (RLMD) · full profile →Form 4 · filed Jan 31, 2024
Net Buying
Open-Market Buys
$126K
Open-Market Sells
$0
Net Open-Market Flow
$126K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2024Buy(P)7K$4.06$28K35K
Jan 30, 2024Buy(P)15K$3.89$58K28K
Jan 29, 2024Buy(P)11K$3.65$39K13K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-008559) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML